Getting an Ozempic prescription starts with understanding what the medication is approved for and whether you’re a candidate. Ozempic is FDA-approved specifically for type 2 diabetes, not weight loss. That distinction shapes every conversation you’ll have with your doctor, your insurance company, and your pharmacy. Here’s what you need to know before your appointment.
What Ozempic Is Actually Approved For
Ozempic (semaglutide) has three FDA-approved uses, and all of them require a type 2 diabetes diagnosis. It’s approved to improve blood sugar control in adults with type 2 diabetes, to reduce the risk of heart attack, stroke, and cardiovascular death in diabetic adults with established heart disease, and to protect kidney function in diabetic adults with chronic kidney disease.
If you’re looking for semaglutide specifically for weight loss, the FDA-approved version for that purpose is Wegovy, not Ozempic. Both contain the same active ingredient, but Wegovy is dosed differently (up to 2.4 mg versus Ozempic’s maximum of 2.0 mg) and is approved for weight management. This matters because your doctor, your insurer, and your pharmacist all operate within these distinctions.
Why Your Doctor Might Prescribe It Off-Label
Despite its diabetes-only approval, many doctors do prescribe Ozempic off-label for weight loss. This became widespread when Wegovy faced severe supply shortages and was difficult to find at pharmacies. Cost differences between the two also pushed patients and prescribers toward Ozempic. Off-label prescribing is legal and common across medicine, but it changes the insurance picture significantly.
Patients who use Ozempic under a doctor’s supervision tend to stay on it longer and get better results. One study found that people with a physician’s prescription used the medication for a median of 12 weeks, compared to just 8 weeks for those who obtained it on their own. Supervised care typically includes nutritional counseling, side effect management, and realistic goal-setting, all of which improve the odds that the medication works as intended. Only about 20% of users in that study followed the recommended dose escalation schedule, which suggests many people are using it in ways that reduce its effectiveness or increase side effects.
What Qualifies You for a Prescription
For the on-label path (type 2 diabetes), the key diagnostic number is your A1C level. An A1C of 6.5% or higher indicates diabetes. Prediabetes falls between 5.7% and 6.4%. If you already have a type 2 diabetes diagnosis and your blood sugar isn’t well controlled with your current treatment, you have a straightforward case for Ozempic.
For the off-label weight loss path, doctors generally follow the same eligibility guidelines used for FDA-approved weight loss medications like Wegovy. Those thresholds are a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. You should also have already tried diet and exercise changes without achieving adequate results.
There are situations where Ozempic is not safe to use. You cannot take it if you or a close family member has a history of medullary thyroid cancer, or if you have a condition called Multiple Endocrine Neoplasia syndrome type 2. A previous serious allergic reaction to semaglutide also rules it out. Your doctor will ask about these during your visit.
How to Prepare for the Conversation
Walking into your appointment with the right information makes a real difference. Doctors respond to patients who understand their own health picture and can articulate a clear reason for the medication. Here’s what to bring or be ready to discuss:
- Your weight history: How long you’ve been at your current weight, what you’ve tried before (calorie tracking, exercise programs, other medications), and what happened.
- Related health conditions: High blood pressure, high cholesterol, sleep apnea, prediabetes, or joint problems that are connected to your weight.
- Recent lab work: If you have recent bloodwork showing your A1C, fasting glucose, or cholesterol numbers, bring it. If not, expect your doctor to order labs before prescribing.
- Family medical history: Particularly any thyroid cancer or diabetes in your family.
Be direct about what you’re asking for and why. You don’t need a script, but saying something like “I’ve been struggling with my weight for several years, I’ve tried X and Y, and I’d like to discuss whether a GLP-1 medication could help” gives your doctor a clear starting point. Physicians are more likely to work with you when you frame it as a collaborative decision rather than a demand for a specific brand.
Why Your Doctor Might Suggest Something Else
Your doctor may recommend a different medication than Ozempic, and it’s worth understanding why. If weight loss is your primary goal and you don’t have diabetes, Wegovy or Zepbound are the FDA-approved options. Wegovy contains the same active ingredient as Ozempic (semaglutide) but at a higher dose designed for weight management. Zepbound uses a different drug called tirzepatide that activates two hormone pathways instead of one, and some patients respond better to it.
Ozempic and Wegovy are single-pathway drugs, while Zepbound and its diabetes counterpart Mounjaro work on two pathways simultaneously. Your doctor may have a preference based on your health profile, what’s available at your pharmacy, or what your insurance covers. Being open to alternatives increases your chances of getting an effective medication sooner.
The Insurance Hurdle
Insurance coverage is often the biggest obstacle. Most insurers will cover Ozempic for type 2 diabetes but not for weight loss. Claims typically get denied when the diagnosis code on the prescription doesn’t match the drug’s approved indication. Some state Medicaid programs have made this explicit: California’s Medi-Cal program, for example, restricts Ozempic coverage to type 2 diabetes and will reject claims submitted for weight loss indications.
Even with a diabetes diagnosis, many insurers require prior authorization. This means your doctor’s office submits documentation proving you meet the criteria, and the insurance company reviews it before approving coverage. Some plans also require “step therapy,” meaning you need to have tried and failed on a less expensive diabetes medication first. Your doctor’s office handles most of this paperwork, but the process can take days to weeks.
If your insurance denies coverage or you don’t have insurance, the out-of-pocket cost for Ozempic is substantial, often running over $900 per month. Novo Nordisk, the manufacturer, offers a savings card that can lower costs for commercially insured patients, but it doesn’t apply to government insurance like Medicare or Medicaid. Some patients turn to compounding pharmacies for cheaper semaglutide, but as of early 2026, semaglutide is no longer on the FDA’s drug shortage list, which limits the legal ability of compounding pharmacies to produce it.
What to Expect After the Prescription
If your doctor writes the prescription, you’ll start at a low dose (typically 0.25 mg per week) and gradually increase over several months. This slow ramp-up is important. It gives your body time to adjust and reduces the nausea, vomiting, and digestive side effects that are common in the first weeks. Many people who quit early do so because they either skip the dose escalation or stop before giving the medication enough time to work. In one study, nearly 60% of people who discontinued did so before completing even 12 weeks.
Ozempic is a once-weekly injection you give yourself, usually in your stomach, thigh, or upper arm. Your doctor’s office or pharmacist will show you how to use the pen. The needle is small and most people find it less painful than expected. You’ll also need follow-up appointments to monitor your blood sugar, weight, and any side effects. The medication works best when paired with changes to your eating habits and physical activity, not as a replacement for them.